Novonesis Human Health Biosolutions is a leading innovator in the field of biosolutions, emerging from the union of Chr. Hansen and Novozymes. With over a century of expertise in microbiome research and an extensive library of more than 100,000 microbial strains, Novonesis is dedicated to enhancing human health at every stage of life. They provide clinically proven probiotics tailored to address diverse gut health challenges, recognizing that health solutions must be personalized to meet individual needs.

At the forefront of innovation, Novonesis offers a unique virtual reality experience called BioLens, which immerses users in the science of the gut-brain connection through guided journeys that link complex science to real-life experiences. They also focus on women's health, delivering scientifically validated supplements aimed at various health concerns. Participating in community events like rooftop gatherings in Barcelona, Novonesis fosters collaboration and knowledge sharing, seeking partnerships that drive impactful health solutions and continuous improvement in health and wellness.